150 related articles for article (PubMed ID: 22550001)
1. Discovery, synthesis, and in vitro evaluation of West Nile virus protease inhibitors based on the 9,10-dihydro-3H,4aH-1,3,9,10a-tetraazaphenanthren-4-one scaffold.
Samanta S; Cui T; Lam Y
ChemMedChem; 2012 Jul; 7(7):1210-6. PubMed ID: 22550001
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro evaluation of West Nile virus protease inhibitors based on the 1,3,4,5-tetrasubstituted 1H-pyrrol-2(5H)-one scaffold.
Gao Y; Samanta S; Cui T; Lam Y
ChemMedChem; 2013 Sep; 8(9):1554-60. PubMed ID: 23868614
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro evaluation of West Nile virus protease inhibitors based on the 2-{6-[2-(5-phenyl-4H-{1,2,4]triazol-3-ylsulfanyl)acetylamino]benzothiazol-2-ylsulfanyl}acetamide scaffold.
Samanta S; Lim TL; Lam Y
ChemMedChem; 2013 Jun; 8(6):994-1001. PubMed ID: 23619931
[TBL] [Abstract][Full Text] [Related]
4. A FRET-based assay for the discovery of West Nile Virus NS2B-NS3 protease inhibitors.
Adamek RN; Maniquis RV; Khakoo S; Bridges MD; Salzameda NT
Bioorg Med Chem Lett; 2013 Sep; 23(17):4848-50. PubMed ID: 23886689
[TBL] [Abstract][Full Text] [Related]
5. Breathing new life into West Nile virus therapeutics; discovery and study of zafirlukast as an NS2B-NS3 protease inhibitor.
Martinez AA; Espinosa BA; Adamek RN; Thomas BA; Chau J; Gonzalez E; Keppetipola N; Salzameda NT
Eur J Med Chem; 2018 Sep; 157():1202-1213. PubMed ID: 30193218
[TBL] [Abstract][Full Text] [Related]
6. HTS identifies novel and specific uncompetitive inhibitors of the two-component NS2B-NS3 proteinase of West Nile virus.
Johnston PA; Phillips J; Shun TY; Shinde S; Lazo JS; Huryn DM; Myers MC; Ratnikov BI; Smith JW; Su Y; Dahl R; Cosford ND; Shiryaev SA; Strongin AY
Assay Drug Dev Technol; 2007 Dec; 5(6):737-50. PubMed ID: 18181690
[TBL] [Abstract][Full Text] [Related]
7. Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication.
Kouretova J; Hammamy MZ; Epp A; Hardes K; Kallis S; Zhang L; Hilgenfeld R; Bartenschlager R; Steinmetzer T
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):712-721. PubMed ID: 28385094
[TBL] [Abstract][Full Text] [Related]
8. Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases.
Nitsche C; Steuer C; Klein CD
Bioorg Med Chem; 2011 Dec; 19(24):7318-37. PubMed ID: 22094280
[TBL] [Abstract][Full Text] [Related]
9. Phosphonate inhibitors of West Nile virus NS2B/NS3 protease.
Skoreński M; Milewska A; Pyrć K; Sieńczyk M; Oleksyszyn J
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):8-14. PubMed ID: 30362835
[TBL] [Abstract][Full Text] [Related]
10. STD-NMR experiments identify a structural motif with novel second-site activity against West Nile virus NS2B-NS3 protease.
Schöne T; Grimm LL; Sakai N; Zhang L; Hilgenfeld R; Peters T
Antiviral Res; 2017 Oct; 146():174-183. PubMed ID: 28927677
[TBL] [Abstract][Full Text] [Related]
11. Novel agmatine dipeptide inhibitors against the West Nile virus NS2B/NS3 protease: a P3 and N-cap optimization study.
Lim HA; Ang MJ; Joy J; Poulsen A; Wu W; Ching SC; Hill J; Chia CS
Eur J Med Chem; 2013 Apr; 62():199-205. PubMed ID: 23353753
[TBL] [Abstract][Full Text] [Related]
12. High-throughput virtual screening lead to discovery of non-peptidic inhibitors of West Nile virus NS3 protease.
Huang D
Methods Mol Biol; 2012; 819():615-23. PubMed ID: 22183561
[TBL] [Abstract][Full Text] [Related]
13. Miniature bovine pancreatic trypsin inhibitors (m-BPTIs) of the West Nile virus NS2B-NS3 protease.
Ang MJ; Lim HA; Poulsen A; Wee JL; Ng FM; Joy J; Hill J; Chia CS
J Enzyme Inhib Med Chem; 2016; 31(sup2):194-200. PubMed ID: 27241372
[TBL] [Abstract][Full Text] [Related]
14. Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: insight into molecular interaction.
Wichapong K; Pianwanit S; Sippl W; Kokpol S
J Mol Recognit; 2010; 23(3):283-300. PubMed ID: 19693793
[TBL] [Abstract][Full Text] [Related]
15. Identification of palmatine as an inhibitor of West Nile virus.
Jia F; Zou G; Fan J; Yuan Z
Arch Virol; 2010 Aug; 155(8):1325-9. PubMed ID: 20496087
[TBL] [Abstract][Full Text] [Related]
16. Tripeptide inhibitors of dengue and West Nile virus NS2B-NS3 protease.
Schüller A; Yin Z; Brian Chia CS; Doan DN; Kim HK; Shang L; Loh TP; Hill J; Vasudevan SG
Antiviral Res; 2011 Oct; 92(1):96-101. PubMed ID: 21763725
[TBL] [Abstract][Full Text] [Related]
17. Peptide inhibitors of West Nile NS3 protease: SAR study of tetrapeptide aldehyde inhibitors.
Knox JE; Ma NL; Yin Z; Patel SJ; Wang WL; Chan WL; Ranga Rao KR; Wang G; Ngew X; Patel V; Beer D; Lim SP; Vasudevan SG; Keller TH
J Med Chem; 2006 Nov; 49(22):6585-90. PubMed ID: 17064076
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel West Nile Virus protease inhibitor based on isobenzonafuranone and triazolic derivatives of eugenol and indan-1,3-dione scaffolds.
de Oliveira AS; Gazolla PAR; Oliveira AFCDS; Pereira WL; de S Viol LC; Maia AFDS; Santos EG; da Silva ÍEP; Mendes TAO; da Silva AM; Dias RS; da Silva CC; Polêto MD; Teixeira RR; de Paula SO
PLoS One; 2019; 14(9):e0223017. PubMed ID: 31557229
[TBL] [Abstract][Full Text] [Related]
19. Small molecule pan-dengue and West Nile virus NS3 protease inhibitors.
Cregar-Hernandez L; Jiao GS; Johnson AT; Lehrer AT; Wong TA; Margosiak SA
Antivir Chem Chemother; 2011 May; 21(5):209-17. PubMed ID: 21566267
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and in vitro evaluation of potential West Nile virus protease inhibitors based on the 1-oxo-1,2,3,4-tetrahydroisoquinoline and 1-oxo-1,2-dihydroisoquinoline scaffolds.
Dou D; Viwanathan P; Li Y; He G; Alliston KR; Lushington GH; Brown-Clay JD; Padmanabhan R; Groutas WC
J Comb Chem; 2010 Nov; 12(6):836-43. PubMed ID: 20882963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
